Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
About this item
Full title
Author / Creator
Publisher
Philadelphia: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Philadelphia: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
In international trials, glucagon-like protein-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2Is) were effective in improving cardiovascular (CV) outcomes.
We assessed the effect of GLP-1RAs and SGLT2Is treatment effect on CV endpoints by geographical region in multiple international trials using random effect...
Alternative Titles
Full title
Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_hal_primary_oai_HAL_inserm_03934843v1
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_hal_primary_oai_HAL_inserm_03934843v1
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1016/j.ahj.2021.06.001
